Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/26/24 18:36 | 11/25/24 | VRNA | Health | Drug | Pharmaceutical Preparations | Hahn Mark W | X0 | O | CFO | 6 | S.m | -5,783 | 4.12 | 0 | -1,405 | 14,340 | D | |||||||||||||||
11/26/24 18:35 | 11/25/24 | VRNA | Health | Drug | Pharmaceutical Preparations | Zaccardelli David | X0 | DO | P,CEO | 6 | S.m | -5,780 | 4.12 | 0 | -1,404 | 15,251 | D | |||||||||||||||
11/26/24 18:34 | 11/25/24 | VRNA | Health | Drug | Pharmaceutical Preparations | Rickard Kathleen A. | X0 | O | Chief Me | 1 | S | -1,176 | 4.90 | 0 | -240 | 2,671 | D | |||||||||||||||
11/18/24 16:20 | 11/18/24 | VRNA | Health | Drug | Pharmaceutical Preparations | Ebsworth David R | X0 | D | 2 | P | 278 | 4.68 | 0 | 59 | 7 | 940 | D | |||||||||||||||
11/7/24 18:56 | 11/6/24 | VRNA | Health | Drug | Pharmaceutical Preparations | Ackermann Christina | X0 | D | 1 | P | 198 | 4.74 | 0 | 42 | 42 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |